Literature DB >> 34224107

Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS.

Anil K Chokkalla1,2, Suresh L Mehta2, Raghu Vemuganti3,4,5.   

Abstract

RNA is more than just a combination of four genetically encoded nucleobases as it carries extra information in the form of epitranscriptomic modifications. Diverse chemical groups attach covalently to RNA to enhance the plasticity of cellular transcriptome. The reversible and dynamic nature of epitranscriptomic modifications allows RNAs to achieve rapid and context-specific gene regulation. Dedicated cellular machinery comprising of writers, erasers, and readers drives the epitranscriptomic signaling. Epitranscriptomic modifications control crucial steps of mRNA metabolism such as splicing, export, localization, stability, degradation, and translation. The majority of the epitranscriptomic modifications are highly abundant in the brain and contribute to activity-dependent gene expression. Thus, they regulate the vital physiological processes of the brain, such as synaptic plasticity, neurogenesis, and stress response. Furthermore, epitranscriptomic alterations influence the progression of several neurologic disorders. This review discussed the molecular mechanisms of epitranscriptomic regulation in neurodevelopmental and neuropathological conditions with the goal to identify novel therapeutic targets.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  5-Methylcytosine; Brain; Inosine; N1-Methyladenosine; N6-Methyladenosine; Pseudouridine; RNA modifications; Stroke

Mesh:

Substances:

Year:  2021        PMID: 34224107      PMCID: PMC8727632          DOI: 10.1007/s12975-021-00927-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  125 in total

Review 1.  Detecting RNA modifications in the epitranscriptome: predict and validate.

Authors:  Mark Helm; Yuri Motorin
Journal:  Nat Rev Genet       Date:  2017-02-20       Impact factor: 53.242

Review 2.  Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases.

Authors:  Anil K Chokkalla; Suresh L Mehta; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-23       Impact factor: 6.200

3.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

Review 4.  Posttranscriptional RNA Modifications: playing metabolic games in a cell's chemical Legoland.

Authors:  Mark Helm; Juan D Alfonzo
Journal:  Chem Biol       Date:  2013-12-05

5.  The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA.

Authors:  Dan Dominissini; Sigrid Nachtergaele; Sharon Moshitch-Moshkovitz; Eyal Peer; Nitzan Kol; Moshe Shay Ben-Haim; Qing Dai; Ayelet Di Segni; Mali Salmon-Divon; Wesley C Clark; Guanqun Zheng; Tao Pan; Oz Solomon; Eran Eyal; Vera Hershkovitz; Dali Han; Louis C Doré; Ninette Amariglio; Gideon Rechavi; Chuan He
Journal:  Nature       Date:  2016-02-10       Impact factor: 49.962

6.  Dynamic landscape and regulation of RNA editing in mammals.

Authors:  Meng How Tan; Qin Li; Raghuvaran Shanmugam; Robert Piskol; Jennefer Kohler; Amy N Young; Kaiwen Ivy Liu; Rui Zhang; Gokul Ramaswami; Kentaro Ariyoshi; Ankita Gupte; Liam P Keegan; Cyril X George; Avinash Ramu; Ni Huang; Elizabeth A Pollina; Dena S Leeman; Alessandra Rustighi; Y P Sharon Goh; Ajay Chawla; Giannino Del Sal; Gary Peltz; Anne Brunet; Donald F Conrad; Charles E Samuel; Mary A O'Connell; Carl R Walkley; Kazuko Nishikura; Jin Billy Li
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

Review 7.  The m6A epitranscriptome: transcriptome plasticity in brain development and function.

Authors:  Ido Livneh; Sharon Moshitch-Moshkovitz; Ninette Amariglio; Gideon Rechavi; Dan Dominissini
Journal:  Nat Rev Neurosci       Date:  2019-12-05       Impact factor: 34.870

8.  N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.

Authors:  Guifang Jia; Ye Fu; Xu Zhao; Qing Dai; Guanqun Zheng; Ying Yang; Chengqi Yi; Tomas Lindahl; Tao Pan; Yun-Gui Yang; Chuan He
Journal:  Nat Chem Biol       Date:  2011-10-16       Impact factor: 15.040

9.  DNAmod: the DNA modification database.

Authors:  Ankur Jai Sood; Coby Viner; Michael M Hoffman
Journal:  J Cheminform       Date:  2019-04-23       Impact factor: 5.514

10.  MODOMICS: a database of RNA modification pathways. 2017 update.

Authors:  Pietro Boccaletto; Magdalena A Machnicka; Elzbieta Purta; Pawel Piatkowski; Blazej Baginski; Tomasz K Wirecki; Valérie de Crécy-Lagard; Robert Ross; Patrick A Limbach; Annika Kotter; Mark Helm; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

View more
  4 in total

1.  Dysregulation of the Epitranscriptomic Mark m1A in Ischemic Stroke.

Authors:  Anil K Chokkalla; Kinga Pajdzik; Xiaoyang Dou; Qing Dai; Suresh L Mehta; Vijay Arruri; Raghu Vemuganti
Journal:  Transl Stroke Res       Date:  2022-06-23       Impact factor: 6.829

Review 2.  Advances in Hydrogel-Based Microfluidic Blood-Brain-Barrier Models in Oncology Research.

Authors:  Ankur Sood; Anuj Kumar; Atul Dev; Vijai Kumar Gupta; Sung Soo Han
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

Review 3.  Noncoding RNA crosstalk in brain health and diseases.

Authors:  Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2021-07-16       Impact factor: 4.297

4.  Chronic corticosterone disrupts the circadian rhythm of CRH expression and m6A RNA methylation in the chicken hypothalamus.

Authors:  Yang Yang; Wanwan Han; Aijia Zhang; Mindie Zhao; Wei Cong; Yimin Jia; Deyun Wang; Ruqian Zhao
Journal:  J Anim Sci Biotechnol       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.